Company Filing History:
1 out of 155 
1 out of 4 Years Active: 2014
Title: Bonnie Ann Avery: A Trailblazing Innovator in Sigma Receptor Ligands
Introduction
Bonnie Ann Avery, an accomplished inventor based in Oxford, Mississippi, has made significant contributions to the field of pharmaceuticals, particularly in the development of highly selective sigma receptor ligands. Her innovative work showcases the complex interplay between chemical structures and their therapeutic potentials, paving the way for future advancements in medicinal chemistry.
Latest Patents
Avery holds a patent for highly selective sigma receptor ligands, detailed as compounds having a general formula that incorporates a variety of complex chemical radicals. These compounds include radicals such as cyano, nitro, acyl, alkyl, and many others, providing a diverse toolkit for pharmaceutical applications. The patent elucidates the intricate molecular frameworks that can be utilized to target specific sigma receptors, offering potential therapeutic benefits in various medical conditions.
Career Highlights
Throughout her career, Bonnie Ann Avery has worked at prestigious institutions, including the University of Mississippi and Université Catholique de Louvain. Her roles in these organizations have allowed her to conduct vital research and develop innovative compounds that contribute to the growing body of knowledge in pharmacology.
Collaborations
Avery's journey in innovation was enhanced through collaborative efforts with esteemed colleagues such as Christopher R. McCurdy and Christophe Mesangeau. These partnerships have fostered an environment of shared knowledge and expertise, driving forward the research and development of her patentable inventions.
Conclusion
Bonnie Ann Avery represents the spirit of modern inventorship, demonstrating the profound impact that innovation can have in science and medicine. With her patent on sigma receptor ligands, she continues to inspire future generations of researchers and inventors to explore the boundaries of chemical science, ultimately contributing to advancements in healthcare.